These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8858453)

  • 21. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
    Lafredo SC; Foleno BD; Fu KP
    Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
    Weigel LM; Anderson GJ; Facklam RR; Tenover FC
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices.
    Biedenbach DJ; Schermer IH; Jones RN
    Diagn Microbiol Infect Dis; 1997; 27(1-2):1-5. PubMed ID: 9127098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.
    Lemmen S; Al-Lahham A; Lütticken R; Reinert RR
    Chemotherapy; 2001; 47(2):104-9. PubMed ID: 11173811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
    Jia W; Wang J; Xu H; Li G
    Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
    Hansen GT; Blondeau JM
    J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.
    Richardson DC; Bast D; McGeer A; Low DE
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1911-4. PubMed ID: 11353652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
    George J; Morrissey I
    J Antimicrob Chemother; 1997 Jun; 39(6):719-23. PubMed ID: 9222040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detection of fluoroquinolone resistance by isothermal chimeric primer-initiated amplification of nucleic acids from clinical isolates of Neisseria gonorrhoeae.
    Horii T; Monji A; Uemura K; Nagura O
    J Microbiol Methods; 2006 Jun; 65(3):557-61. PubMed ID: 16278026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.
    Barry AL; Fuchs PC; Citron DM; Allen SD; Wexler HM
    J Antimicrob Chemother; 1993 Jun; 31(6):893-900. PubMed ID: 8395494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbroth versus agar dilution for susceptibility testing of fluoroquinolones and other agents against anaerobic bacteria.
    Krepel CJ; Gohr CM; Edmiston CE; Condon RE
    J Antimicrob Chemother; 1993 Oct; 32(4):571-5. PubMed ID: 8288498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers.
    Ives TJ; Marston EL; Regnery RL; Butts JD
    Int J Antimicrob Agents; 2001 Sep; 18(3):217-22. PubMed ID: 11673033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of E test with conventional agar MICs for quinolones.
    Holt HA; Bowker K; Bedford KA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1994 Feb; 33(2):356. PubMed ID: 8182022
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid antimicrobial susceptibility test using tetrazolium reduction.
    Bartlett RC; Mazens MF
    Antimicrob Agents Chemother; 1979 Jun; 15(6):769-74. PubMed ID: 475361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E test: a novel technique for antimicrobial susceptibility testing.
    Sader HS; Pignatari AC
    Sao Paulo Med J; 1994; 112(4):635-8. PubMed ID: 7481427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility testing: general principles and contemporary practices.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 1998 Apr; 26(4):973-80. PubMed ID: 9564485
    [No Abstract]   [Full Text] [Related]  

  • 38. A fast, practical and reproducible procedure for the standardization of the cell density of an Aspergillus suspension.
    Araujo R; Rodrigues AG; Pina-Vaz C
    J Med Microbiol; 2004 Aug; 53(Pt 8):783-786. PubMed ID: 15272066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of antibiotic resistance in vitro.
    Greenwood D
    Int J Antimicrob Agents; 2000 May; 14(4):303-6. PubMed ID: 10794951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agreement of Quantitative and Qualitative Antimicrobial Susceptibility Testing Methodologies: The Case of Enrofloxacin and Avian Pathogenic
    Temmerman R; Goethals K; Garmyn A; Vanantwerpen G; Vanrobaeys M; Haesebrouck F; Antonissen G; Devreese M
    Front Microbiol; 2020; 11():570975. PubMed ID: 33042075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.